UVEAL MELANOMA, METASTATIC
Clinical trials for UVEAL MELANOMA, METASTATIC explained in plain language.
Never miss a new study
Get alerted when new UVEAL MELANOMA, METASTATIC trials appear
Sign up with your email to follow new studies for UVEAL MELANOMA, METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise for rare eye cancer that spreads
Disease control Recruiting nowThis study tests an experimental drug called NBM-BMX for people with metastatic uveal melanoma, a rare eye cancer that has spread to other parts of the body. The goal is to find the best dose, check for side effects, and see if the drug can shrink tumors or slow the cancer. About…
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Novelwise Pharmaceutical Corporation • Aim: Disease control
Last updated May 26, 2026 07:13 UTC
-
New radioactive drug targets tough melanoma
Disease control Recruiting nowThis early-stage trial tests an investigational drug for adults with melanoma that has spread or cannot be surgically removed. The main goals are to find the safest dose and understand side effects. Participants receive the drug once every 6 weeks for up to 6 doses, with regular …
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1 • Sponsor: Alpha-9 Oncology USA Inc. • Aim: Disease control
Last updated May 26, 2026 06:52 UTC
-
New combo trial hopes to boost immune attack on eye cancer
Disease control Recruiting nowThis early-phase study tests whether adding a new drug (roginolisib) to an existing immunotherapy (tebentafusp) is safe and tolerable for people with advanced uveal melanoma, a rare eye cancer. Only 8 participants with a specific genetic type (HLA-A*02:01) will be enrolled. The g…
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1 • Sponsor: St Vincent's Hospital, Sydney • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New drug MBS8(1V270) enters human testing for advanced cancers
Disease control Recruiting nowThis early-stage study tests a new drug called MBS8(1V270) in about 106 people with advanced solid tumors that have not responded to standard treatments. The main goal is to check safety and find the best dose. Researchers will also look for early signs that the drug shrinks tumo…
Matched conditions: UVEAL MELANOMA, METASTATIC
Phase: PHASE1 • Sponsor: MonTa Biosciences ApS • Aim: Disease control
Last updated May 15, 2026 11:53 UTC